Chris Williamson: We Almost Have the Tech to Live Forever – David Friedberg
Peer-Reviewed Research
Key Takeaways
- Monitor developments in epigenetic resetting technologies like Yamanaka factors, which are showing promising results in reversing aging at the cellular level in animal models.
- Stay updated on clinical trials from companies like Altos Labs and Sinclair’s ventures, as they are advancing these technologies for systemic human use.
- Prepare for potential lifestyle shifts as longevity treatments could extend healthy, productive lives, changing how society views work and leisure.
Products & Gear Mentioned
- Altos Labs – A highly funded biotech startup focused on longevity research.
Notable Quotes
“We are now discovering not just the four proteins, but a whole bunch of other little molecules that we can put into a cocktail… it will get into our cells and it will reset the epigenetics of that cell to make it young again.”
Bottom Line
Stay informed about breakthroughs in epigenetic resetting technologies and clinical trials, as they could soon revolutionize aging and healthspan.
Shop the gear mentioned in this video
As an Amazon Associate, we earn from qualifying purchases.
Explore More
- Compare All Protocols — side-by-side protocols
Watch the Full Video
Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.
Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.
No spam. Unsubscribe anytime. Powered by Beehiiv.
Related Research
From Our Research Network
Daily longevity researchZone2 Training
Exercise protocolsSleep Science
Sleep optimization
Part of the Evidence-Based Research Network
